Anastrozole,Exemestane,Letrozole,Tamoxifen
Astrazeneca,Novartis,Pfizer
['breast']
fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine vs chemoendocrine therapy: results from the tailorx patient-reported outcomes substudy from currently presenting at #asco22 
An interdisciplinary international journal of the American Cancer Society. Editor-in-Chief: Suresh S. Ramalingam, MD (@RamalingamMD)